Literature DB >> 32340768

Risk of reactivation or reinfection of novel coronavirus (COVID-19).

Javad Alizargar1.   

Abstract

Entities:  

Mesh:

Year:  2020        PMID: 32340768      PMCID: PMC7177092          DOI: 10.1016/j.jfma.2020.04.013

Source DB:  PubMed          Journal:  J Formos Med Assoc        ISSN: 0929-6646            Impact factor:   3.282


× No keyword cloud information.
I read with great interest the article by Cheng et al. in which they tried to introduce the first confirmed case of novel coronavirus pneumonia (COVID-19) in Taiwan and described her self-recovery process. Joob et al. expressed their concerns about the infection that remains under-detected with self-recovery assumptions in another correspondence paper. In a letter to the editor paper that later published in the journal of Formosan medical association, Cheng et al. confirmed that negative results have been obtained four times from sputum and throat and also urine in this patient. Due to the expansion of the COVID-19 epidemy in different parts of the world, more and more cases are getting infected and of course, many people will be recovering from this viral infection as today April 22 in Taiwan, only 6 deaths have been reported out of 426 cases and 236 patients with confirmed infection have been released from the isolation. So, it is very important to be sure about the negative cases to be truly negative. Another concern is the reactivation of cases that got the infection, recovered and left isolation. This issue has been brought to the public attention as on April 13, South Korea reported that 116 recovered cases of COVID-19 has been found positive again. As Korean approach to mark a patient as negative is two negative samples in within 24 h more precautions seem to be needed to be sure a patient had truly recovered from COVID-19 or may not reactivate again after recovery.

Declaration of Competing Interest

The authors have no conflicts of interest relevant to this article.
  3 in total

1.  Author reply to Letters to the Editor "COVID-19 pneumonia in Taiwan".

Authors:  Shao-Chung Cheng; Yu-Long Fan Chiang; Chia-Husn Huang; Yuan-Nian Hsu
Journal:  J Formos Med Assoc       Date:  2020-04-02       Impact factor: 3.282

2.  First case of Coronavirus Disease 2019 (COVID-19) pneumonia in Taiwan.

Authors:  Shao-Chung Cheng; Yuan-Chia Chang; Yu-Long Fan Chiang; Yu-Chan Chien; Mingte Cheng; Chin-Hua Yang; Chia-Husn Huang; Yuan-Nian Hsu
Journal:  J Formos Med Assoc       Date:  2020-02-26       Impact factor: 3.282

3.  COVID-19 pneumonia in Taiwan.

Authors:  Beuy Joob; Viroj Wiwanitkit
Journal:  J Formos Med Assoc       Date:  2020-04-02       Impact factor: 3.282

  3 in total
  19 in total

1.  Primary Immune Response Provides Protective Efficacy against SARS-CoV-2 Reinfection.

Authors:  Rupendra Shrestha; Reena Shrestha; Ram Bahadur Khadka; Rabin Gyawali
Journal:  JNMA J Nepal Med Assoc       Date:  2021-07-30       Impact factor: 0.556

Review 2.  Heparin-binding Peptides as Novel Therapies to Stop SARS-CoV-2 Cellular Entry and Infection.

Authors:  Omid Tavassoly; Farinaz Safavi; Iman Tavassoly
Journal:  Mol Pharmacol       Date:  2020-09-10       Impact factor: 4.436

Review 3.  COVID-19: Is reinfection possible?

Authors:  Aratã Oliveira Cortez Costa; Humberto de Carvalho Aragão Neto; Ana Paula Lopes Nunes; Ricardo Dias de Castro; Reinaldo Nóbrega de Almeida
Journal:  EXCLI J       Date:  2021-03-02       Impact factor: 4.068

4.  COVID-19 Reinfection.

Authors:  Mohammed I Habadi; Tarig H Balla Abdalla; Nashaat Hamza; Afnan Al-Gedeei
Journal:  Cureus       Date:  2021-01-15

5.  Recurrent COVID-19 including evidence of reinfection and enhanced severity in thirty Brazilian healthcare workers.

Authors:  Letícia Adrielle Dos Santos; Pedro Germano de Góis Filho; Ana Maria Fantini Silva; João Victor Gomes Santos; Douglas Siqueira Santos; Marília Marques Aquino; Rafaela Mota de Jesus; Maria Luiza Dória Almeida; João Santana da Silva; Daniel M Altmann; Rosemary J Boyton; Cliomar Alves Dos Santos; Camilla Natália Oliveira Santos; Juliana Cardoso Alves; Ianaline Lima Santos; Lucas Sousa Magalhães; Emilia M M A Belitardo; Danilo J P G Rocha; João P P Almeida; Luis G C Pacheco; Eric R G R Aguiar; Gubio Soares Campos; Silvia Inês Sardi; Rejane Hughes Carvalho; Amélia Ribeiro de Jesus; Karla Freire Rezende; Roque Pacheco de Almeida
Journal:  J Infect       Date:  2021-02-13       Impact factor: 6.072

6.  Clinical characteristics of SARS-CoV-2 by re-infection vs. reactivation: a case series from Iran.

Authors:  Mostafa Salehi-Vaziri; Tahmineh Jalali; Behrokh Farahmand; Fatemeh Fotouhi; Mohammad Banifazl; Mohammad Hassan Pouriayevali; Mona Sadat Larijani; Neda Afzali; Amitis Ramezani
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2021-03-18       Impact factor: 3.267

Review 7.  SARS-CoV-2 Reinfection among Healthcare Workers in Mexico: Case Report and Literature Review.

Authors:  Brenda Garduño-Orbe; Juan Manuel Sánchez-Rebolledo; Mustafá Cortés-Rafael; Yuliana García-Jiménez; Marcelina Perez-Ortiz; Indira Rocío Mendiola-Pastrana; Eduardo López-Ortiz; Geovani López-Ortiz
Journal:  Medicina (Kaunas)       Date:  2021-05-03       Impact factor: 2.430

8.  Mass-Spectrometric Detection of SARS-CoV-2 Virus in Scrapings of the Epithelium of the Nasopharynx of Infected Patients via Nucleocapsid N Protein.

Authors:  Evgeny N Nikolaev; Maria I Indeykina; Alexander G Brzhozovskiy; Anna E Bugrova; Alexey S Kononikhin; Natalia L Starodubtseva; Evgeny V Petrotchenko; Grigoriy I Kovalev; Christoph H Borchers; Gennady T Sukhikh
Journal:  J Proteome Res       Date:  2020-08-19       Impact factor: 4.466

9.  Analysis of Risk Factors on Readmission Cases of COVID-19 in the Republic of Korea: Using Nationwide Health Claims Data.

Authors:  Woo-Hwi Jeon; Jeong Yeon Seon; So-Youn Park; In-Hwan Oh
Journal:  Int J Environ Res Public Health       Date:  2020-08-12       Impact factor: 3.390

10.  Kinetics of SARS-CoV-2 positivity of infected and recovered patients from a single center.

Authors:  Jia Huang; Le Zheng; Zhen Li; Shiying Hao; Fangfan Ye; Jun Chen; Hayley A Gans; Xiaoming Yao; Jiayu Liao; Song Wang; Manfei Zeng; Liping Qiu; Chunyang Li; John C Whitin; Lu Tian; Henry Chubb; Kuo-Yuan Hwa; Scott R Ceresnak; Wei Zhang; Ying Lu; Yvonne A Maldonado; Doff B McElhinney; Karl G Sylvester; Harvey J Cohen; Lei Liu; Xuefeng B Ling
Journal:  Sci Rep       Date:  2020-10-29       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.